Turning Point Benefit Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-233
Closed -$48.2K 460
2025
Q4
$48.2K Buy
233
+10
+4% +$1.98K 0.03% 148
2025
Q3
$41.5K Buy
+223
New +$38.2K 0.03% 150

Other funds holding JNJ

Turning Point Benefit Group's JNJ Position: Q1 2026 in Review

Turning Point Benefit Group sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 233 shares — an estimated $48.2K sold.

Turning Point Benefit Group first reported a position in JNJ in Q3 2025 and held it in 2 quarters. The position peaked at $48.2K in Q4 2025. 4,641 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Turning Point Benefit Group reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Turning Point Benefit Group sold 233 Johnson & Johnson shares in Q1 2026, an estimated $48.2K.
  • Turning Point Benefit Group first reported a position in Johnson & Johnson in Q3 2025 and held it in 2 quarters.
  • Turning Point Benefit Group's Johnson & Johnson position peaked at $48.2K in Q4 2025.
  • 4,641 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Turning Point Benefit Group's 13F filing for Q1 2026, filed 12 May 2026.